Citadel Advisors
PAHC icon

Citadel Advisors’s Phibro Animal Health PAHC Stock Holding History

Citadel Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-400
Closed -$6.71K – 14953
2024
Q2 		$6.71K Sell
400
-1,700
-81% -$27.3K ﹤0.01% 13313
2024
Q1 		$27.2K Sell
2,100
-3,100
-60% -$37.2K ﹤0.01% 12783
2023
Q4 		$60.2K Buy
+5,200
New +$58.7K ﹤0.01% 11589
2023
Q3 		– Sell
-3,100
Closed -$42.5K – 14877
2023
Q2 		$42.5K Sell
3,100
-800
-21% -$11.5K ﹤0.01% 12000
2023
Q1 		$59.7K Buy
3,900
+1,600
+70% +$24.4K ﹤0.01% 11936
2022
Q4 		$30.8K Buy
+2,300
New +$30.8K ﹤0.01% 12716
2015
Q4 		– Sell
-1,000
Closed -$32K – 9060
2015
Q3 		$32K Buy
+1,000
New +$36.5K ﹤0.01% 7879

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Citadel Advisors's PAHC Position: Q1 2026 in Review

Citadel Advisors sold out of Phibro Animal Health (PAHC) in Q1 2026, closing a stake of 47,446 shares — an estimated $2.26M sold.

Citadel Advisors first reported a position in PAHC in Q2 2014 and held it in 38 quarters. The position peaked at $4.96M in Q1 2019. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Citadel Advisors reported no remaining Phibro Animal Health position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 47,446 Phibro Animal Health shares in Q1 2026, an estimated $2.26M.
  • Citadel Advisors first reported a position in Phibro Animal Health in Q2 2014 and held it in 38 quarters.
  • Citadel Advisors's Phibro Animal Health position peaked at $4.96M in Q1 2019.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.